Our Pricing

Saxenda vs Mounjaro Single Pen: Clinical Comparison for UK Patients

Published on: June 03, 2026

Choosing between saxenda vs mounjaro single pen uk options requires understanding how these prescription weight loss injections differ in mechanism, efficacy, and dosing schedules. At Cured Pharmacy, our UK-registered clinical team helps you compare both treatments with transparent pricing from £135.00 ensuring you select the most appropriate option based on your individual medical history and weight loss goals.

Saxenda vs Mounjaro Single Pen UK: Key Differences Explained

Saxenda contains liraglutide, a GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1 to regulate appetite and blood sugar levels [1]. Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA, activating both glucose-dependent insulinotropic polypeptide and GLP-1 pathways simultaneously [2]. This dual mechanism produces significantly different clinical outcomes in weight loss trials.

The fundamental difference lies in dosing frequency and treatment duration. Saxenda requires daily subcutaneous injections, with each single pen delivering doses for approximately 6 days at the maintenance dose of 3.0mg [1]. Mounjaro uses a once-weekly injection schedule, with each KwikPen containing four doses for a month's treatment [2]. UK patients often find the weekly schedule more convenient for long-term adherence, though individual preferences vary based on lifestyle and injection tolerance.

Both medications are prescription-only in the UK and require clinical assessment by a registered prescriber before dispensing. At Cured Pharmacy, our free online consultation takes under three minutes, with UK prescribers reviewing your medical history, current medications, and weight loss objectives to determine suitability for either treatment. All consultations are conducted in accordance with GPhC guidelines under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

Clinical Efficacy: Mounjaro vs Saxenda Weight Loss Results

Head-to-head clinical trials demonstrate substantial differences in average weight loss outcomes between these two medications. In the SURPASS-3 trial, patients receiving the highest maintenance dose of tirzepatide (Mounjaro) achieved an average body weight reduction of 22.5% over 72 weeks [2]. By comparison, the SCALE Obesity and Prediabetes trial showed liraglutide (Saxenda) produced an average weight loss of 8.0% over 56 weeks at the 3.0mg daily dose [1].

These differences reflect the dual-pathway mechanism of tirzepatide versus the single GLP-1 pathway of liraglutide. The GIP component in Mounjaro enhances insulin secretion and may improve fat metabolism more effectively than GLP-1 stimulation alone [2]. However, individual responses vary considerably, and some patients may experience better tolerability or more consistent results with the daily dosing pattern of Saxenda.

UK prescribers typically consider several factors when recommending one treatment over the other, including baseline BMI, previous weight loss attempts, tolerance to gastrointestinal side effects, and patient preference for injection frequency. Both medications require commitment to dietary modifications and increased physical activity to achieve optimal results, as demonstrated in clinical trials where lifestyle interventions were implemented alongside pharmacotherapy [1][2].

Time to Results: What UK Patients Can Expect

Saxenda typically shows initial weight loss within the first four weeks of treatment, with gradual dose escalation from 0.6mg to the maintenance dose of 3.0mg over five weeks [1]. Mounjaro follows a similar titration schedule, starting at 2.5mg weekly and increasing every four weeks to minimise gastrointestinal side effects, with maximum efficacy typically observed after 20-24 weeks at the maintenance dose [2]. UK prescribers recommend a minimum 12-week trial period to assess treatment response before considering alternative options.

Side Effects and Tolerability: Saxenda or Mounjaro Which Is Better

Both medications share a similar side effect profile, predominantly affecting the gastrointestinal system. The most commonly reported adverse effects include nausea, diarrhoea, constipation, vomiting, and abdominal discomfort [1][2]. These symptoms typically emerge during dose escalation and diminish over 4-8 weeks as the body adapts to treatment. In clinical trials, approximately 44% of liraglutide patients and 81% of tirzepatide patients at the highest dose experienced gastrointestinal side effects [1][2].

The higher incidence of side effects with tirzepatide reflects both the dual-pathway mechanism and the higher average weight loss achieved. However, severe adverse events leading to treatment discontinuation occurred in similar proportions across both medications—approximately 6-9% of trial participants [1][2]. UK prescribers manage tolerability through careful dose titration, dietary counselling to reduce fat intake during initial weeks, and temporary dose adjustments if symptoms become problematic.

Contraindications differ slightly between the two treatments. Neither medication should be used in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [1][2]. Saxenda carries additional cautions for patients with inflammatory bowel disease or diabetic gastroparesis due to its effects on gastric emptying [1]. Your UK prescriber will conduct a thorough medical history review during your online consultation to identify any contraindications before prescribing either treatment.

Dosing and Administration: Single Pen Comparison

The Saxenda single pen is a pre-filled, multi-dose injection device containing 18mg of liraglutide in 3ml solution. Each pen delivers doses from 0.6mg to 3.0mg in 0.6mg increments, providing approximately 6 days of treatment at the maintenance dose [1]. Patients inject subcutaneously into the abdomen, thigh, or upper arm once daily, ideally at the same time each day to maintain consistent blood levels. The pen does not require refrigeration after first use but should be stored below 30°C and discarded after 30 days.

Mounjaro KwikPen comes as a single-dose, pre-filled pen containing one weekly dose of tirzepatide in strengths ranging from 2.5mg to 15mg. Each pen is used once and discarded, eliminating the need for dose dialling or multi-use storage concerns [2]. UK patients inject once weekly on the same day each week, with flexibility to change the injection day if needed, provided at least 72 hours have elapsed since the previous dose. Unused pens must be stored in the refrigerator between 2-8°C until the expiration date.

Injection technique is straightforward for both medications, with comprehensive instructions provided by Cured Pharmacy alongside your prescription. Most UK patients become comfortable with self-injection within 1-2 administrations. Rotating injection sites reduces the risk of lipodystrophy, and both medications can be injected regardless of meal timing, though taking Saxenda at the same time daily may help with routine adherence.

Storage and Handling Requirements

Proper storage ensures medication efficacy throughout the treatment period. Saxenda pens in use may be kept at room temperature (below 30°C) for up to 30 days, making it convenient for UK patients who travel frequently [1]. Mounjaro pens can be kept at room temperature (up to 30°C) for up to 21 days if needed, though refrigeration is preferred for unused pens [2]. Both medications should be protected from direct sunlight and never frozen, as freezing permanently damages the active ingredient.

Cost Comparison: Saxenda vs Mounjaro UK Pricing

At Cured Pharmacy, Saxenda is available from £135.00 and Mounjaro from £124.99 with final pricing determined by your prescribed dose and treatment duration. These prices include your medication, free UK prescriber consultation, and discreet next-day delivery across the UK. We display all costs upfront before your consultation begins, ensuring complete transparency without hidden fees or subscription requirements.

When comparing monthly treatment costs, consider that Saxenda requires approximately 5 pens per month at the maintenance dose, whilst Mounjaro requires one pen per week (4-5 pens monthly depending on the month). The cost-per-week calculation varies based on your prescribed maintenance dose, which your UK prescriber determines after assessing your treatment response during the initial titration period. Many patients find the convenience of weekly dosing with Mounjaro offsets the higher per-pen cost, though individual budgets and insurance coverage influence this decision.

Cured Pharmacy guarantees the lowest prices in the UK for genuine, MHRA-licensed weight loss medications. Unlike some online services, we never require long-term subscriptions or bulk purchases. You can order month-by-month based on your treatment progress and clinical need, with the flexibility to pause or adjust your prescription after consultation with your UK prescriber. Our commitment to transparent pricing means the amount you see during checkout is the final amount you pay, with no surprise charges.

How to Order Saxenda or Mounjaro Online at Cured Pharmacy

Ordering prescription weight loss medication from Cured Pharmacy follows a straightforward, fully regulated process. Begin by clicking 'Start Assessment' on either the Saxenda or Mounjaro product page. Our online consultation form takes under three minutes to complete and covers your medical history, current medications, weight loss goals, and any previous experience with GLP-1 treatments. This information is reviewed by a UK-registered prescriber, typically within 24 hours on weekdays.

If your prescriber approves treatment, they will issue a valid UK prescription and determine the appropriate starting dose based on your clinical profile. Your medication is then dispensed by our GPhC-registered pharmacy (registration number 9012511) and dispatched via tracked courier in 100% discreet packaging. Most UK addresses receive next-day delivery, with no branding or pharmacy details visible on the exterior packaging to protect your privacy.

For ongoing treatment, you will need a new prescription each time you reorder, as UK regulations require regular clinical review for prescription-only medications. Our system sends reminders when you are due for reassessment, and repeat consultations are equally straightforward. Your prescriber may adjust your dose based on treatment response, tolerability, and weight loss progress. Should you experience any concerns during treatment, our clinical team is available by phone at (+44) 116 4646009 during business hours for medical guidance.

What Happens After Your Consultation

Once your UK prescriber reviews your consultation, you will receive email notification of their decision within 24 hours on weekdays. If approved, your prescription is automatically sent to our dispensing team, and you will receive tracking information once your order is dispatched. If your prescriber identifies any clinical concerns or contraindications, they will explain why treatment cannot be provided and may suggest alternative options from our weight loss range, subject to clinical suitability and your preferences.

Scientific References

1. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
4. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
5. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and lifestyle changes. Cured Pharmacy operates under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073) and is registered with the General Pharmaceutical Council (GPhC 9012511).